SlideShare a Scribd company logo
ANTINEOPLASTIC
AGENTS
Name- Ranjit S. Jadhav
Subject – Medicinal Chemistry
College – Rajarambapu College of Pharmacy , Kasegaon

Cancer* is a term used for diseases in which abnormal cells divide without control and are able to
invade other tissues. Cancer cells can spread to other parts of the body through the blood and
lymph systems, this process is called metastasis.

•
Characteristics of Cancer Cells:
Cancer involves the development and reproduction of abnormal cells•
Cancer cells are usually nonfunctional•
Cancer cell growth is not subject to normal body control mechanisms
2
WHAT IS CELL CYCLE???
LIFE CYCLE OF CANCER
6
WHAT IS CANCER???
• Cancer is a term used for diseases in which
abnormal cells divide without control and
are able to invade other tissues. Cancer cells
can spread to other parts of the body
through the blood and lymph systems.
TYPES OF CANCER
• Carcinoma - cancer that begins in the skin or in tissues that line or cover
internal organs. There are a number of subtypes of carcinoma,
including adenocarcinoma basal cell carcinoma, squamous cell carcinoma
and transitional cell carcinoma.
• Sarcoma - cancer that begins in bone, cartilage, fat, muscle, blood vessels,
or other connective or supportive tissue.
• Leukemia - cancer that starts in blood-forming tissue such as the bone
marrow and causes large numbers of abnormal blood cells to be produced
and enter the blood.
• Lymphoma and myeloma - cancers that begin in the cells of the immune
system
TYPES OF TUMORS
• Not all tumors are cancerous; tumors can be benign or
malignant.
• Benign tumors aren't cancerous. They can often be
removed, and, in most cases, they do not come back. Cells
in benign tumors do not spread to other parts of the body.
• Malignant tumors are cancerous. Cells in these tumors can
invade nearby tissues and spread to other parts of the
body. The spread of cancer from one part of the body to
another is called metastasis.
10
Cancer Therapeutic Modalities (classical)
1. Surgery
2. Radiation
3. Chemotherapy
1/3 of patients without metastasis
Respond to surgery and radiation.
If diagnosed at early stage,
close to 50% cancer
could be cured.
50% patients will undergo chemotherapy,
to remove micrometastasis. However,
chemotherapy is able to cure only about 10-15%
of all cancer patients.
Antineoplastic Agent
 Cell Cycle Specific (CCS) agents
 Cell Cycle Non-Specific (CCNS) agents
 Miscellaneous (e.g., antibodies) agents
12
G0 = resting phase
G1 = pre-replicative phase
G2 = post-replicative phase
S = DNA synthesis
M = mitosis or cell division
M
S
G2 G1 Hydrocortisone
Actinomycin D
5-Fluorouracil
Cytosine arabinoside
Methotrexate
6-Mercaptopurine
6-Thioguanine
Purine antagonists
Methotrexate
Cyclophosphamide
5-Fluorouracil
Cytosine arabinoside
Daunomycin
Vincristine,Vinblastine
Paclitaxel, Docetaxel
Cyclophosphamide
Bleomycin
Actinomycin D
G0
resting
Cell cycle specificity of Anti-Neoplastic Agents
16
CLASSIFICATION
1. ALKYLATING AGENTS
• A. Nitrogen Mustards: Cyclophosphamide
• B. Alkyl Sulfonate: Busulfan
• C. Nitrosoureas :Carmustine,Lomustine
• D. Triazenes : Dacarbazine & Procarbazine
2. Antimetabolites
• A. Folate antagonist: Methotrexate
• B. Purine analogues: Thioguanine( 5-TG)
• C. Pyrimidine analogues: 5-Flurouracil
• 3. Plant-derived products :
• Vinca alkaloids -Vincristine, Vinblastine
• 4. Antibiotics : Doxorubicin , Daunorubicin , Bleomycin,
Mitomycin, Dactinomycin
• 5. Hormones and related drugs : Tamoxifen
• 6. Miscellaneous agent : Cisplatin
• Structure-
• Cyclophosphamide Busulfan
• Carmustine Lomustine
• Dacarbazine Procarbazine
• Methotrexate Thioguanine( 5-TG)
• 5-Flurouracil Vincristine & Vinblastine
• Doxorubicin & Daunorubicin
• Tamoxifen Cisplatin
MECHANISM OF ACTION: ALKYLATING AGENT
• Alkylating agents exert their cytotoxic effects via transfer
of their alkyl groups to various cellular constituents.
• Alkylations of DNA within the nucleus probably represent
the major interactions that lead to cell death.
• The major site of alkylation within DNA is the n7 position
of guanine; however, other bases are also alkylated to
lesser degrees, including n1 and n3 of adenine, n3 of
cytosine, and o6 of guanine
• These compounds produce highly reactive carbonium ion intermediates
which transfer alkyl groups to cellular macro molecules by forming
covalent bonds.
• Alkylation results in cross linking / abnormal base pairing/scission of
DNA.
SAR of Cyclophosphamide
MOA: ANTI METABOLITES
• Antimetabolites are drugs that are
structurally related to naturally occurring
compounds, such as vitamins, amino acids,
and nucleotides.
• These drugs can compete for binding sites
on enzymes or can themselves become
incorporated into DNA or RNA and thus
interfere with cell growth and
proliferation.
• Methotrxate
• Inhibits DNA synthesis by competitively and irreversibly inhibiting
enzyme, dihydrofolate reductase (DHFR) which converts
dihydrofolate to tetrahydrofolate essential for DNA synthesis.
Thank you !

More Related Content

What's hot

Alkylating Agents & Anti-metabolites Chemotherapy
Alkylating Agents & Anti-metabolites ChemotherapyAlkylating Agents & Anti-metabolites Chemotherapy
Alkylating Agents & Anti-metabolites Chemotherapy
Aaditya Prakash
 
Chapter 23 topoisomerase inhibitors
Chapter 23 topoisomerase inhibitorsChapter 23 topoisomerase inhibitors
Chapter 23 topoisomerase inhibitors
Nilesh Kucha
 
Alkylating anticancers
Alkylating anticancersAlkylating anticancers
Alkylating anticancersnoody4ever
 
1 introduction of cancer-medicinal chemistry
1 introduction of cancer-medicinal chemistry1 introduction of cancer-medicinal chemistry
1 introduction of cancer-medicinal chemistry
United States International University - Africa
 
Antitubercular agents
Antitubercular agentsAntitubercular agents
Antitubercular agents
GaneshDevane
 
Introduction to chemotherapy of cancer
Introduction to chemotherapy of cancerIntroduction to chemotherapy of cancer
Introduction to chemotherapy of cancer
Subramani Parasuraman
 
Antimetabolites
AntimetabolitesAntimetabolites
Antimetabolites
SabaMustafa11
 
2. alkylating & anti-metabolite drugs
2. alkylating  &  anti-metabolite drugs2. alkylating  &  anti-metabolite drugs
2. alkylating & anti-metabolite drugs
HarshikaPatel6
 
TAXANES AND PODOPHYLLOTOXINS
TAXANES AND PODOPHYLLOTOXINSTAXANES AND PODOPHYLLOTOXINS
Cancer Chemotherapy
Cancer ChemotherapyCancer Chemotherapy
Cancer Chemotherapyazsyed
 
Neoplasm and Antineoplastic Agents
Neoplasm and Antineoplastic AgentsNeoplasm and Antineoplastic Agents
Neoplasm and Antineoplastic Agents
pankaj patel
 
ANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKAR
ANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKARANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKAR
ANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKAR
Dr. Ravi Sankar
 
Tetracyclines
TetracyclinesTetracyclines
Tetracyclines
Dr. Ravi Sankar
 
Anticancer DRUG
Anticancer DRUG Anticancer DRUG
Anticancer DRUG
suraj wanjari
 
Microtubule inhibitors
Microtubule inhibitorsMicrotubule inhibitors
Microtubule inhibitors
LAKSHMI DEEPTHI GEDELA
 
Anticancer drug from plant
Anticancer drug from plantAnticancer drug from plant
Anticancer drug from plant
Zainab&Sons
 
Anticancer drugs 2 alkylating agents
Anticancer drugs 2 alkylating agentsAnticancer drugs 2 alkylating agents
Anticancer drugs 2 alkylating agentsSubramani Parasuraman
 
Anti metabolites
Anti metabolitesAnti metabolites
Anti metabolites
Dr VARUN RAGHAVAN
 
ANTICANCER.pdf
ANTICANCER.pdfANTICANCER.pdf
ANTICANCER.pdf
Jasmine Chaudhary
 
Principles of cancer chemotherapy
Principles of cancer chemotherapyPrinciples of cancer chemotherapy
Principles of cancer chemotherapy
Sufyan Akram
 

What's hot (20)

Alkylating Agents & Anti-metabolites Chemotherapy
Alkylating Agents & Anti-metabolites ChemotherapyAlkylating Agents & Anti-metabolites Chemotherapy
Alkylating Agents & Anti-metabolites Chemotherapy
 
Chapter 23 topoisomerase inhibitors
Chapter 23 topoisomerase inhibitorsChapter 23 topoisomerase inhibitors
Chapter 23 topoisomerase inhibitors
 
Alkylating anticancers
Alkylating anticancersAlkylating anticancers
Alkylating anticancers
 
1 introduction of cancer-medicinal chemistry
1 introduction of cancer-medicinal chemistry1 introduction of cancer-medicinal chemistry
1 introduction of cancer-medicinal chemistry
 
Antitubercular agents
Antitubercular agentsAntitubercular agents
Antitubercular agents
 
Introduction to chemotherapy of cancer
Introduction to chemotherapy of cancerIntroduction to chemotherapy of cancer
Introduction to chemotherapy of cancer
 
Antimetabolites
AntimetabolitesAntimetabolites
Antimetabolites
 
2. alkylating & anti-metabolite drugs
2. alkylating  &  anti-metabolite drugs2. alkylating  &  anti-metabolite drugs
2. alkylating & anti-metabolite drugs
 
TAXANES AND PODOPHYLLOTOXINS
TAXANES AND PODOPHYLLOTOXINSTAXANES AND PODOPHYLLOTOXINS
TAXANES AND PODOPHYLLOTOXINS
 
Cancer Chemotherapy
Cancer ChemotherapyCancer Chemotherapy
Cancer Chemotherapy
 
Neoplasm and Antineoplastic Agents
Neoplasm and Antineoplastic AgentsNeoplasm and Antineoplastic Agents
Neoplasm and Antineoplastic Agents
 
ANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKAR
ANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKARANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKAR
ANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKAR
 
Tetracyclines
TetracyclinesTetracyclines
Tetracyclines
 
Anticancer DRUG
Anticancer DRUG Anticancer DRUG
Anticancer DRUG
 
Microtubule inhibitors
Microtubule inhibitorsMicrotubule inhibitors
Microtubule inhibitors
 
Anticancer drug from plant
Anticancer drug from plantAnticancer drug from plant
Anticancer drug from plant
 
Anticancer drugs 2 alkylating agents
Anticancer drugs 2 alkylating agentsAnticancer drugs 2 alkylating agents
Anticancer drugs 2 alkylating agents
 
Anti metabolites
Anti metabolitesAnti metabolites
Anti metabolites
 
ANTICANCER.pdf
ANTICANCER.pdfANTICANCER.pdf
ANTICANCER.pdf
 
Principles of cancer chemotherapy
Principles of cancer chemotherapyPrinciples of cancer chemotherapy
Principles of cancer chemotherapy
 

Similar to Antineoplastic agents

Cellular-abberation.pptx
Cellular-abberation.pptxCellular-abberation.pptx
Cellular-abberation.pptx
KristelAnne5
 
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
CANCER:  A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSISCANCER:  A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
Charu Pundir
 
Drugs used in cancer.pptm
Drugs used in cancer.pptmDrugs used in cancer.pptm
Drugs used in cancer.pptm
DEVIN YADAV
 
ANTICANCER.ppt
ANTICANCER.pptANTICANCER.ppt
ANTICANCER.ppt
tesa10
 
ONCOLOGY.pptx
ONCOLOGY.pptxONCOLOGY.pptx
ONCOLOGY.pptx
georginansiah247
 
ch7neoplasia-.pptx
ch7neoplasia-.pptxch7neoplasia-.pptx
ch7neoplasia-.pptx
vandana thakur
 
Chemo shah done2
Chemo shah done2Chemo shah done2
Chemo shah done2
Dr.Shah Khalid
 
cancer biology introduction and features of cancer.pptx
cancer biology  introduction and features of cancer.pptxcancer biology  introduction and features of cancer.pptx
cancer biology introduction and features of cancer.pptx
binaya tamang
 
Oncology
OncologyOncology
TUMOR MARKERS.......................pptx
TUMOR MARKERS.......................pptxTUMOR MARKERS.......................pptx
TUMOR MARKERS.......................pptx
ahamdsarayreh
 
cancer
cancercancer
cancer and its anticancer drugs
cancer and its anticancer drugs cancer and its anticancer drugs
cancer and its anticancer drugs
rasika walunj
 
Benign & malignant growth Pathology
Benign & malignant growth PathologyBenign & malignant growth Pathology
Benign & malignant growth Pathology
Anamika Ramawat
 
Taniya slide share
Taniya slide shareTaniya slide share
Taniya slide share
Taniya M S
 
Understanding Tumors and Their Impact.pptx
Understanding Tumors and Their Impact.pptxUnderstanding Tumors and Their Impact.pptx
Understanding Tumors and Their Impact.pptx
NoorulainMehmood1
 
cancer how when and what
cancer how when and whatcancer how when and what
cancer how when and what
Sarah Mohammed
 
Cancer signaling pathway
Cancer signaling pathwayCancer signaling pathway
Cancer signaling pathway
Osaid Al Meanazel
 
CANCER...................................pptx
CANCER...................................pptxCANCER...................................pptx
CANCER...................................pptx
Cherry
 
Cancer and its treatment
Cancer and its treatmentCancer and its treatment
Cancer and its treatmentPallavi Oberoi
 
Anti-Neoplastic Drugs-1.pptx
Anti-Neoplastic Drugs-1.pptxAnti-Neoplastic Drugs-1.pptx
Anti-Neoplastic Drugs-1.pptx
MuhammadAbbasWali
 

Similar to Antineoplastic agents (20)

Cellular-abberation.pptx
Cellular-abberation.pptxCellular-abberation.pptx
Cellular-abberation.pptx
 
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
CANCER:  A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSISCANCER:  A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
 
Drugs used in cancer.pptm
Drugs used in cancer.pptmDrugs used in cancer.pptm
Drugs used in cancer.pptm
 
ANTICANCER.ppt
ANTICANCER.pptANTICANCER.ppt
ANTICANCER.ppt
 
ONCOLOGY.pptx
ONCOLOGY.pptxONCOLOGY.pptx
ONCOLOGY.pptx
 
ch7neoplasia-.pptx
ch7neoplasia-.pptxch7neoplasia-.pptx
ch7neoplasia-.pptx
 
Chemo shah done2
Chemo shah done2Chemo shah done2
Chemo shah done2
 
cancer biology introduction and features of cancer.pptx
cancer biology  introduction and features of cancer.pptxcancer biology  introduction and features of cancer.pptx
cancer biology introduction and features of cancer.pptx
 
Oncology
OncologyOncology
Oncology
 
TUMOR MARKERS.......................pptx
TUMOR MARKERS.......................pptxTUMOR MARKERS.......................pptx
TUMOR MARKERS.......................pptx
 
cancer
cancercancer
cancer
 
cancer and its anticancer drugs
cancer and its anticancer drugs cancer and its anticancer drugs
cancer and its anticancer drugs
 
Benign & malignant growth Pathology
Benign & malignant growth PathologyBenign & malignant growth Pathology
Benign & malignant growth Pathology
 
Taniya slide share
Taniya slide shareTaniya slide share
Taniya slide share
 
Understanding Tumors and Their Impact.pptx
Understanding Tumors and Their Impact.pptxUnderstanding Tumors and Their Impact.pptx
Understanding Tumors and Their Impact.pptx
 
cancer how when and what
cancer how when and whatcancer how when and what
cancer how when and what
 
Cancer signaling pathway
Cancer signaling pathwayCancer signaling pathway
Cancer signaling pathway
 
CANCER...................................pptx
CANCER...................................pptxCANCER...................................pptx
CANCER...................................pptx
 
Cancer and its treatment
Cancer and its treatmentCancer and its treatment
Cancer and its treatment
 
Anti-Neoplastic Drugs-1.pptx
Anti-Neoplastic Drugs-1.pptxAnti-Neoplastic Drugs-1.pptx
Anti-Neoplastic Drugs-1.pptx
 

Recently uploaded

STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
kimdan468
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
DhatriParmar
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
Krisztián Száraz
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
goswamiyash170123
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 

Recently uploaded (20)

STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 

Antineoplastic agents

  • 1. ANTINEOPLASTIC AGENTS Name- Ranjit S. Jadhav Subject – Medicinal Chemistry College – Rajarambapu College of Pharmacy , Kasegaon
  • 2.  Cancer* is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer cells can spread to other parts of the body through the blood and lymph systems, this process is called metastasis.  • Characteristics of Cancer Cells: Cancer involves the development and reproduction of abnormal cells• Cancer cells are usually nonfunctional• Cancer cell growth is not subject to normal body control mechanisms 2
  • 3. WHAT IS CELL CYCLE???
  • 4.
  • 5. LIFE CYCLE OF CANCER
  • 6. 6
  • 7. WHAT IS CANCER??? • Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer cells can spread to other parts of the body through the blood and lymph systems.
  • 8.
  • 9. TYPES OF CANCER • Carcinoma - cancer that begins in the skin or in tissues that line or cover internal organs. There are a number of subtypes of carcinoma, including adenocarcinoma basal cell carcinoma, squamous cell carcinoma and transitional cell carcinoma. • Sarcoma - cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. • Leukemia - cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of abnormal blood cells to be produced and enter the blood. • Lymphoma and myeloma - cancers that begin in the cells of the immune system
  • 10.
  • 11.
  • 12. TYPES OF TUMORS • Not all tumors are cancerous; tumors can be benign or malignant. • Benign tumors aren't cancerous. They can often be removed, and, in most cases, they do not come back. Cells in benign tumors do not spread to other parts of the body. • Malignant tumors are cancerous. Cells in these tumors can invade nearby tissues and spread to other parts of the body. The spread of cancer from one part of the body to another is called metastasis.
  • 13. 10 Cancer Therapeutic Modalities (classical) 1. Surgery 2. Radiation 3. Chemotherapy 1/3 of patients without metastasis Respond to surgery and radiation. If diagnosed at early stage, close to 50% cancer could be cured. 50% patients will undergo chemotherapy, to remove micrometastasis. However, chemotherapy is able to cure only about 10-15% of all cancer patients.
  • 14. Antineoplastic Agent  Cell Cycle Specific (CCS) agents  Cell Cycle Non-Specific (CCNS) agents  Miscellaneous (e.g., antibodies) agents
  • 15. 12 G0 = resting phase G1 = pre-replicative phase G2 = post-replicative phase S = DNA synthesis M = mitosis or cell division M S G2 G1 Hydrocortisone Actinomycin D 5-Fluorouracil Cytosine arabinoside Methotrexate 6-Mercaptopurine 6-Thioguanine Purine antagonists Methotrexate Cyclophosphamide 5-Fluorouracil Cytosine arabinoside Daunomycin Vincristine,Vinblastine Paclitaxel, Docetaxel Cyclophosphamide Bleomycin Actinomycin D G0 resting Cell cycle specificity of Anti-Neoplastic Agents
  • 16. 16
  • 17. CLASSIFICATION 1. ALKYLATING AGENTS • A. Nitrogen Mustards: Cyclophosphamide • B. Alkyl Sulfonate: Busulfan • C. Nitrosoureas :Carmustine,Lomustine • D. Triazenes : Dacarbazine & Procarbazine 2. Antimetabolites • A. Folate antagonist: Methotrexate • B. Purine analogues: Thioguanine( 5-TG) • C. Pyrimidine analogues: 5-Flurouracil
  • 18. • 3. Plant-derived products : • Vinca alkaloids -Vincristine, Vinblastine • 4. Antibiotics : Doxorubicin , Daunorubicin , Bleomycin, Mitomycin, Dactinomycin • 5. Hormones and related drugs : Tamoxifen • 6. Miscellaneous agent : Cisplatin
  • 19. • Structure- • Cyclophosphamide Busulfan • Carmustine Lomustine
  • 20. • Dacarbazine Procarbazine • Methotrexate Thioguanine( 5-TG)
  • 22. • Doxorubicin & Daunorubicin
  • 24. MECHANISM OF ACTION: ALKYLATING AGENT • Alkylating agents exert their cytotoxic effects via transfer of their alkyl groups to various cellular constituents. • Alkylations of DNA within the nucleus probably represent the major interactions that lead to cell death. • The major site of alkylation within DNA is the n7 position of guanine; however, other bases are also alkylated to lesser degrees, including n1 and n3 of adenine, n3 of cytosine, and o6 of guanine
  • 25. • These compounds produce highly reactive carbonium ion intermediates which transfer alkyl groups to cellular macro molecules by forming covalent bonds. • Alkylation results in cross linking / abnormal base pairing/scission of DNA.
  • 27. MOA: ANTI METABOLITES • Antimetabolites are drugs that are structurally related to naturally occurring compounds, such as vitamins, amino acids, and nucleotides. • These drugs can compete for binding sites on enzymes or can themselves become incorporated into DNA or RNA and thus interfere with cell growth and proliferation.
  • 28.
  • 29. • Methotrxate • Inhibits DNA synthesis by competitively and irreversibly inhibiting enzyme, dihydrofolate reductase (DHFR) which converts dihydrofolate to tetrahydrofolate essential for DNA synthesis.
  • 30.
  • 31.